Emergent BioSolutions Inc. — Director's Dealing 2015

Mar 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2015-03-10

Reporting Person: El-Hibri Fuad (Director, Chairman, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-10	Common Stock	A	36219	$0.00	Acquired	2004129	Direct
2015-03-10	Common Stock	F	5128	$29.00	Disposed	1999001	Direct
2015-03-11	Common Stock	F	1906	$28.99	Disposed	1997095	Direct
2015-03-12	Common Stock	F	1463	$28.67	Disposed	1995632	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-10	Employee Stock Option (right to buy)	$28.99	A	72413	Acquired	2022-03-09	Common Stock (72413)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2350331	Indirect
Common Stock	1524155	Indirect

Footnotes

F1: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.

F2: Mr. El-Hibri's restricted stock units vest in three equal annual installments on March 9, 2016, March 9, 2017 and March 9, 2018 assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of Common Stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.

F3: Mr. El-Hibri's holdings through Intervac, L.L.C. include 1,638,403 shares of Common Stock held by Mr. El-Hibri and his wife, as tenants by the entirety, through their 37.7% equity interest in Intervac, L.L.C.; 127,721 shares held by Mr. El-Hibri's wife; and 584,207 shares held by trusts indirectly controlled by Mr. El-Hibri or his wife. Mr. El-Hibri disclaims beneficial ownership, for purposes of Section 16 of the Exchange Act or otherwise, of those shares held solely by his wife and those shares held by the trusts.

F4: Mr. El-Hibri holds individually and with his wife, as tenants by the entirety, an aggregate 89.2% equity interest in Biovac, L.L.C. Biovac, L.L.C. is the direct owner of 1,524,155 shares of Common Stock. Mr. El-Hibri disclaims beneficial ownership of the shares of Common Stock directly owned by Biovac, L.L.C. for purposes of Section 16, except to the extent of his pecuniary interest in 1,359,546 shares.

F5: Vests in three equal installments on March 9, 2016, March 9, 2017 and March 9, 2018.